-
Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsight
04 Jan 2023 21:50 GMT
… , Ginkgo Bioworks, Sumitomo Pharma, MYMETICS, Merck KGaA, BioNTech, Jiangsu … risks in the malaria pipeline landscape.
Malaria Overview
Malaria is an acute … the emerging malaria pipeline therapies @ Malaria Clinical Trials
Malaria Therapeutics Assessment
…
-
Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsight
04 Jan 2023 18:00 GMT
… , Ginkgo Bioworks, Sumitomo Pharma, MYMETICS, Merck KGaA, BioNTech, Jiangsu … risks in the malaria pipeline landscape. Malaria Overview Malaria is an acute … the emerging malaria pipeline therapies @ Malaria Clinical Trials Malaria Therapeutics Assessment …
-
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
31 Aug 2022 21:25 GMT
… of the parties involved.
About Mymetics
Mymetics Corporation (OTCQB:MYMX) is a … ;AIDS and malaria, and collaborative projects in the cancer immunotherapy.
Mymetics… further information, please visit www.mymetics.com.
For further information, please …
-
Malaria Vaccines Market 2019- Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026
12 Jul 2019 11:28 GMT
… on WiseGuyReports.
Introduction
Global Malaria Vaccines Market
In the … malaria vaccines market are VLP Therapeutics, GlaxoSmithKline Plc, Sanaria Inc., Mymetics … Corporation, others. The Global Malaria Vaccines Markett report …
-
Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast...
23 Apr 2018 08:40 GMT
… CEO of Anergis.
About Mymetics
Mymetics Corporation (OTCQB:MYMX) is … AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus … RSV vaccine. HIV, malaria and
intra-nasal influenza … of treatment.
CONTACTS:
Mymetics Corporation
Ronald Kempers
Chief …
-
Mymetics to Present New Preclinical Data on Thermostable and Cold-Chain Independent Virosome based Vaccines
13 Sep 2017 12:21 GMT
… AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus … RSV vaccine. HIV, malaria and intra-nasal influenza … with rationally designed antigens. Mymetics' vaccines are … virosome-based vaccine candidates.
Mymetics acts as coordinator and …
-
Mymetics' HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute
11 Apr 2016 07:36 GMT
… are well documented.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) … 47;AIDS, intranasal Influenza, Malaria, Herpes Simplex Virus and … trial for its Malaria vaccine on children … parasitic diseases responsible for malaria, schistosomiasis and Chagas disease …
-
Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate
05 Apr 2016 06:53 GMT
… study with Mymetics' virosome based formulations for a malaria transmission- … compared to other malaria transmission-blocking vaccine constructs.
Mymetics has shown separately … Influenza, Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics…
-
Mymetics Announces Discontinuation of the RSV Collaborative Project
29 Jan 2016 03:25 GMT
… Mymetics' virosome based vaccine candidates for HIV and Malaria … this transfer.
About Mymetics
Mymetics Corporation (OTCQB: MYMX … Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics … rationally designed antigens. Mymetics' vaccines are …
-
Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain ...
20 Apr 2015 07:40 GMT
… Agreement No 646122.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) … Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics’ … stage marketplace.
Contacts
Mymetics Corporation
Ronald Kempers
CEO …
About
© 1995-2025